The synaptic marker NPTX2 and longitudinal brain atrophy among cognitively unimpaired adults
Claire L Anderson, Juan Vazquez, Yuxin Zhu, Corinne Pettigrew, Abhay Moghekar, Guray Erus, Christos Davatzikos, Mei‐Fang Xiao, Paul F Worley, Marilyn S. Albert, Anja Soldan · 2025
Read The synaptic marker NPTX2 and longitudinal brain atrophy among cognitively unimpaired adults by Claire L Anderson, Juan Vazquez, Yuxin Zhu, Corinne Pettigrew, Abhay Moghekar, Guray Erus, Christos Davatzikos, Mei‐Fang Xiao, Paul F Worley, Marilyn S. Albert, Anja Soldan (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714496.txt.
Description
Claire Anderson and co-authors published this study in two thousand twenty-five on a synapse protein called NPTX2 and brain shrinkage over time. Past work tied higher spinal fluid levels of this protein to lower risk of slipping from normal thinking into impairment.
The team followed two hundred thirteen adults who were thinking normally at the start, some for well over a decade. Brain scans tracked shrinkage in regions hit early by Alzheimer's and in regions tied to plain aging. People with higher NPTX2 at the start lost less tissue in both sets of regions. Alzheimer's marker levels drove shrinkage too, but they did not change the NPTX2 link. The authors say a healthy synapse protein may guard brain tissue broadly. That makes it a marker worth watching in early prevention work.
Catalog record
| CREATOR | Claire L Anderson, Juan Vazquez, Yuxin Zhu, Corinne Pettigrew, Abhay Moghekar, Guray Erus, Christos Davatzikos, Mei‐Fang Xiao, Paul F Worley, Marilyn S. Albert, Anja Soldan |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |